Paeds Vivas · rheumatology-musculoskeletal-and-sports
Performance-enhancing substances in young athletes — branching viva
Branching viva on performance-enhancing substances in the young athlete: the WADA prohibited list and strict liability, the recognition of anabolic-androgenic steroid use through the physical signs and the confidential history, the cardiovascular growth and psychiatric harms including the suicidal withdrawal, the counselling-first management, and the contaminated-supplement inadvertent-doping scenario.
On this page
Study tools
Target exams
Candidate brief
You are the adolescent-medicine registrar in the clinic. You have eight minutes to answer the examiner's questions on the young athlete below. The viva branches through the diagnostic framework, the pathophysiology and the harm, the management, and then to a second scenario on inadvertent doping. Be prepared to justify each answer with the underlying mechanism and the relevant evidence. [1] [6]
References5ShowHide
- [1]Calfee R, Fadale P. Popular ergogenic drugs and supplements in young athletes. Pediatrics, 2006.PMID 16510635
- [4]Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Annals of Epidemiology, 2014.PMID 24582699
- [5]Goldberg L, Elliot D, Clarke GN, MacKinnon DP, Moe E, et al. Effects of a multidimensional anabolic steroid prevention intervention. The Adolescents Training and Learning to Avoid Steroids (ATLAS) Program. JAMA, 1996.PMID 8918852
- [6]Mulcahey MK, Schiller JR, Hulstyn MJ. Anabolic steroid use in adolescents: identification of those at risk and strategies for prevention. The Physician and Sportsmedicine, 2010.PMID 20959703
- [9]Kozhuharov VR, Ivanov K, Ivanova S. Dietary Supplements as Source of Unintentional Doping. BioMed Research International, 2022.PMID 35496041